Accuray ARAY
NASDAQ ARAY
$0.28 -0.01 (-3.90%)
At close: Aug 21, 2026 · 4:00 PM EDT

Accuray (ARAY) Income from Non-Controlling Interests (2011 - 2025)

Accuray (ARAY) posted quarterly Income from Non-Controlling Interests of $439000.0 for Q2 2025, up 709.72% year-over-year from $54216.1 in Q2 2024, and down 88.53% quarter-over-quarter from $3.8 million in Q4 2024.

Accuray (ARAY) Income from Non-Controlling Interests (2011 - 2025) Analysis & Trends

Accuray's Income from Non-Controlling Interests history runs 12 years deep, the most recent figure standing at $439000.0 for Q2 2025.

  • In Q2 2025, Income from Non-Controlling Interests rose 709.72% year-over-year to $439000.0; the TTM figure through Jun 2025 stood at $5.8 million (up 504.17% YoY), while the FY2025 annual figure was $439000.0, up 709.72% from the prior year.
  • Income from Non-Controlling Interests for Q2 2025 stood at $439000.0, down from $3.8 million in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $3.8 million in Q4 2024, with the low at -$1.2 million in Q3 2021.
  • The 5-year median for Income from Non-Controlling Interests is $431000.0 (2023), against an average of $505461.5.
  • The sharpest annual moves came in 2021 and 2025: Income from Non-Controlling Interests tumbled 1114.29% in 2021, then soared 709.72% in 2025.
  • Accuray's Income from Non-Controlling Interests stood at $740000.0 in 2021, then jumped by 162.97% to $1.9 million in 2022, then tumbled by 47.17% to $1.0 million in 2023, then soared by 272.47% to $3.8 million in 2024, then sank by 88.53% to $439000.0 in 2025.
  • Business Quant data shows ARAY's Income from Non-Controlling Interests at $439000.0 in Q2 2025, $3.8 million in Q4 2024, and $1.6 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -2.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -500,000.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 13.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 2.32 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 900,000.00
10 Accuray 35.28 Mn -4.42 Mn 25.29 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 439,000.00
Dec 31, 2024 3.83 Mn
Sep 30, 2024 1.60 Mn
Jun 30, 2024 -72,000.00
Dec 31, 2023 1.03 Mn
Sep 30, 2023 -427,000.00
Jun 30, 2023 431,000.00
Dec 31, 2022 1.95 Mn
Sep 30, 2022 -1.07 Mn
Jun 30, 2022 -368,000.00
Dec 31, 2021 740,000.00
Sep 30, 2021 -1.17 Mn
Jun 30, 2021 -340,000.00
Dec 31, 2020 1.02 Mn
Sep 30, 2020 1.09 Mn
Jun 30, 2020 -28,000.00
Mar 31, 2020 -149,000.00
Mar 31, 2018 319,000.00
Dec 31, 2017 102,000.00
Sep 30, 2017 22,000.00